A. . Blauvelt, L. Eichenfeld, M. Kuligowski, M. Venturanza, K. Sun, and J. Silverberg, “Long-term safety and disease control with ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies”, J of Skin, vol. 5, no. 6, p. s65, Nov. 2021.